A Study in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated
Clinical trial NCT03868540 · TERMINATED
Trial details
- NCT number
- NCT03868540
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-28
- Primary completion
- 2019-11-25
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.